2024年6月9日在港安醫療中心-銅鑼灣舉行之 “Lung Cancer Screening and Early Diagnosis” 研討會已經圓滿結束。是次研討會由 癌症資訊網 cancerinformation.com.hk 、香港精確腫瘤醫學會 和 關愛社會醫生聯會 合辦。
感謝專家和講者對肺癌早期檢測和診斷的詳細講解和貢獻。
【CME Programme】
是次活動參與的醫生均可申請 自願延續醫學教育計劃
CME points will be awarded by the following colleges:
Hong Kong College of Community Medicine (1.50 points )
Hong Kong College of Emergency Medicine (1.50 points )
The Hong Kong College of Family Physicians (2 points )
The Hong Kong College of Pathologists ( 2 points )
Hong Kong College of Physicians (1 points )
Hong Kong College of Radiologists (1.50 points )
The College of Surgeons of Hong Kong ( 2 points )
Medical Council of Hong Kong ( 2 points )
特別感謝：
Dr. Joseph Au
Dr. Henry Pang
Dr. Billy Chiu
Miss Natalie Fong
Miss Zanonia Chiu
Symposium “Lung Cancer Screening and Early Diagnosis” held on 9 June 2024 at Adventist Medical Center-CWB. The Host of organizers are Hong Kong Precision Oncology Society, Association of Doctors for Social Responsibility and Cancerinformation.com.hk .
Grateful for Our Expert Speakers on Lung Cancer Early Detection and Diagnosis.
We are thrilled to extend our deepest gratitude to the exceptional speakers who contributed to our recent event on Lung Cancer Early Detection and Diagnosis. Their combined expertise provided a well-rounded and informative session, making a significant impact on all attendees.
Big thanks to:
Dr. Henry Pang, General Practitioner, for offering critical insights into early detection from a primary care perspective.
Dr. Joseph Au, Clinical Oncologist, for discussing the latest diagnostic techniques and treatment modalities.
Our Chairlady Miss Natalie Fong, for shedding light on the vital support services available through charitable organizations.
Miss Zanonia Chiu, Registered Clinical Psychologist, for addressing the crucial role of mental health support for patients and their families.
Dr. Billy Chiu, Chief Medical Executive, for providing a beautiful venue at the Adventist Medical Center Causeway Bay and hosting the Q&A session and providing closing remarks.
Blessed is the one who perseveres under trial because, having stood the test, that person will receive the crown of life that the Lord has promised to those who love him. （James 1:12)
• Health tech pioneers unveiled latest non-invasive detective tools and treatments for cervical precancers, including urine HPV test, menstrual pads and cold light PDT system, during Women’s breakfast
• More than 250 rising and veteran investors convened at the annual conference, raising over HKD 3 million to envision a healthier future for all
Fireside chat at the Inaugural Sohn Hong Kong Women’s Breakfast centred on state-of-the-art diagnostic tools and therapeutic technologies.
27 May 2024, Hong Kong – The Inaugural Sohn Hong Kong Women’s Breakfast and the 12th Annual Sohn Hong Kong Investment Leaders Conference, presented by the Karen Leung Foundation (KLF) in partnership with the Sohn Conference Foundation, successfully concluded on 23 May, 2024. Over 300 leading hedge funds, asset managers, finance professionals from across Asia’s investment community and healthcare visionaries convened for the events. Over HKD 3 million was raised, bringing the total proceeds for the charity over the 12-year period to HKD 30 million, which all contributed towards KLF’s mission of supporting the fight against gynaecological cancers and improving women’s health in Hong Kong.
Female Visionaries Reshaping Healthcare with Frontier Diagnostics and Care
The first exclusive women’s breakfast debuted in Hong Kong, showcasing an inspirational fireside chat featuring a pioneering female entrepreneur, biomedical scientist and biotech leader working towards empowering women with improved health knowledge and more effective detective tools and treatments to combat HPV and cervical cancers.
“By honouring Karen Leung’s wish to save lives by reducing the impact of gynaecological cancers in Hong Kong, we are proud to debut this breakfast session to recognise and celebrate innovators at the forefront of advancing women’s health. Their work holds tremendous promise for early detection, prevention and treatment of female cancers affecting millions of women worldwide,” said Katharina Reimer, Executive Director at KLF.
Alia Rahman, Co-Founder and CEO of Amplexd Therapeutics, introduced two topical breakthrough therapies for treatment of cervical precancers. “Once approved, our goal is to provide an alternative to the traditional ‘watch and wait’ approach and invasive surgery to minimise discomfort, and enable more accessible treatments,” she noted. “We are enthused to partner with KLF, who has long supported our mission since inception, to jointly develop strategies that advance our shared goal of eliminating cervical cancer.”
Dr. Pui-Wah Choi, Founder of WomenX, unveiled the latest progress of menstrual pads for HPV testing and detecting cervical cancer markers. “With our ‘Pads for Future Women’,women can now get checked and informed with ease. It provides an accessible pathway for cervical cancer screening, breaking down the barriers for women to take full control of their health,” said Dr. Choi. “We stand committed to empowering women with knowledge and resources until every woman triumphs over cervical cancer.”
Dr. Ricky Chiu, Founder and Chairman at PHASE Scientific, highlighted the world’s first urine test for early HPV detection. “Our private, convenient, and non-invasive urine HPV testing serves as an alternative to safeguard women’s cervical health, addressing their concerns over traditional screening.” He added, “We encourage the Hong Kong government and health organisations to consider making this new screening method widely available,especially for underserved communities.”
Investing For Good: Navigating Market Trends with Asia’s Elite and Emerging Investors
Orienting the half-day conference was the spotlight on the Next Wave programme, where next-generation fund managers unveiled prospective investment ideas in companies with strong growth potential, across sectors spanning from manufacturing, home appliances and entertainment to recruitment. The conference was followed by insightful pitches by leading hedge funds and investors, shedding light on growing investment opportunities in Asia-Pacific markets found in industries ranging from automotives, new energy, utilities and mining to consumer electronics, media, healthcare and real estate. Key highlights included:
• Wendy Chen, Founder and CIO at Sigmoid Capital, described Sanrio (8136 JT) as the “hidden gem in the Japanese equity market”, highlighting the company’s massive portfolio of beloved intellectual property (IP) headlined by Hello Kitty.
• Daniel Rupp, Founder and CIO at Parkway Capital, took a closer look at Chinese company Haier (690D.DE), a global leader in household appliances, diving into its unique position and competitive landscape, and noting their D-Shares.
• Seth Fischer, Founder and CIO at Oasis Management, saw upside potential for the Japanese mid-cap OTC company, Kobayashi Pharmaceutical (4967 JT), drawing attention to the company’s potential for improved crisis management and privatisation.
• Aaron Stern, Managing Partner and CIO at Converium Capital, explored the unchartered opportunities such as sovereign bonds of the Republic of Ecuador (XS2214238441), which are traded at larger discounts and have a higher bond yield than peers.
• Lloyd Moffatt, Founding Partner at Wickhams Hill, presented a non-consensus view and warned about the enormous downside potential of Lifestyle Communities (LIC.AU) and the loss of competitiveness of investment opportunities in the Australian property market.
“Throughout the past 12 years, the Sohn Hong Kong Investment Leaders Conference has raised essential funds and heightened public awareness towards gynaecological cancers,”Katharina added. “We are immensely grateful for the continued support from the community,which exemplifies our shared goal of ‘investing for good’ and brings us closer to new treatment options and cures to gynaecological cancers. Together, we enable all women to live healthy and fulfilling lives.”
About Karen Leung Foundation The Karen Leung Foundation (KLF) is working to save lives in Hong Kong by raising awareness of gynaecological cancer, educating women to increase rates of early detection and ensuring that women in treatment have access to optimal medical care. Founded in 2013,we are the first and only organisation in Hong Kong solely devoted to women’s gynaecological cancers. To date, the Karen Leung Foundation has raised more than HK$38 million to fight gynaecological cancer and help Hong Kong girls and women. The Karen Leung Foundation honours the memory of Karen Leung, a hedge fund trader, who died at age 35 following a diagnosis of metastatic cervical cancer.
About Sohn Conference Foundation
The Sohn Conference Foundation is dedicated to the treatment and cure of paediatric cancer and other childhood diseases. The Foundation supports cutting edge medical research, stateof-the-art research equipment, and innovative programmes to ensure that children with cancer survive and thrive. The Foundation raises its funds through premier investment conferences and special events, including its renowned annual New York Sohn Investment Conference.Founded in 1995, the Conference honours the memory of Ira Sohn, a Wall Street Professional who lost his battle with cancer at age 29. The Foundation has expanded its reach to include the Sohn Australia, Sohn Canada, Sohn Geneva, Sohn Hong Kong, Sohn India, Sohn London,Sohn San Francisco, and Sohn Tel Aviv. To date, the Foundation has raised more than $95 million globally. More information on the Sohn Investment Conference is available at www.sohnconference.org.
